Marian Yvette Williams-Brown
Research Subjects
Marian Yvette Williams-Brown has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Ciaran B. Trace
School of Information, The University of Texas at Austin, Austin, USA
2 shared publications - Siqi Yi
School of Automation, Guangdong University of Technology, Guangzhou, 510006, China
2 shared publications - Yan Zhang
School of Information, The University of Texas at Austin, Austin, Texas, USA
2 shared publications A. Newtson
Univ Nebraska Med Ctr, Dept Obstet & Gynecol, Omaha, NE USA
1 shared publicationAlexandra Perez
Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX
1 shared publicationAnanya Murthy
1 shared publication
Latest Publications
- Open Access
- 22 October 2026
- Published by Elsevier in SSRN Electronic Journal
The Coverage Gap: The Impact of Economic Factors on the Utilization of Standard of Care Brachytherapy in Locally Advanced Cervical Cancer in the United States
OBJECTIVE: Brachytherapy with radiation therapy (RT) improves survival in locally advanced cervical cancer (LACC) but is underutilized. Associated demographic and financial factors were examined. STUDY DESIGN: This retrospective claims-based cohort study investigated LACC patients undergoing definitive treatment (2015-2021). Multivariable logistic regression identified factors independently associated with brachytherapy receipt, including radiation oncologist density (ROD) per 100,000 population (in quartiles). RESULTS: Among 2,555 patients, 47.7% received brachytherapy. 52.3% received RT alone. Concurrent chemotherapy most strongly predicted brachytherapy (adjusted odds ratio [aOR]:6.45;95% confidence interval [CI]:4.77-8.72). Compared with other plans, enrollment in HMOs (aOR:1.96; 95%CI:1.47-2.60) or PPOs (aOR:1.36; 95%CI:1.10-1.67) was associated with higher brachytherapy odds. Increasing age was associated with lower odds. Moderate ROD (Q2&Q3) was associated with higher brachytherapy odds (Q2 aOR:2.20; 95%CI:1.64-2.96; Q3 aOR:2.34; 95%CI:1.75-3.12), but not low (Q1) or high density (Q4). CONCLUSION: The nonlinear ROD association suggests workforce volume alone will not address gaps. Variation across insurance plans suggests structural financing factors influence RT modality.
- 22 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessThe Coverage Gap: The Impact of Economic Factors on the Utilization of Standard of Care Brachytherapy in Locally Advanced Cervical Cancer in the United States
OBJECTIVE: Brachytherapy with radiation therapy (RT) improves survival in locally advanced cervical cancer (LACC) but is underutilized. Associated demographic and financial factors were examined. STUDY DESIGN: This retrospective claims-based cohort study investigated LACC patients undergoing definitive treatment (2015-2021). Multivariable logistic regression identified factors independently associated with brachytherapy receipt, including radiation oncologist density (ROD) per 100,000 population (in quartiles). RESULTS: Among 2,555 patients, 47.7% received brachytherapy. 52.3% received RT alone. Concurrent chemotherapy most strongly predicted brachytherapy (adjusted odds ratio [aOR]:6.45;95% confidence interval [CI]:4.77-8.72). Compared with other plans, enrollment in HMOs (aOR:1.96; 95%CI:1.47-2.60) or PPOs (aOR:1.36; 95%CI:1.10-1.67) was associated with higher brachytherapy odds. Increasing age was associated with lower odds. Moderate ROD (Q2&Q3) was associated with higher brachytherapy odds (Q2 aOR:2.20; 95%CI:1.64-2.96; Q3 aOR:2.34; 95%CI:1.75-3.12), but not low (Q1) or high density (Q4). CONCLUSION: The nonlinear ROD association suggests workforce volume alone will not address gaps. Variation across insurance plans suggests structural financing factors influence RT modality.
- 24 September 2024
- Published by World Scientific Pub Co Pte Ltd in Journal of Medical Robotics Research
- Vol. 09 (03n04)
Training with a Visual-Haptic Simulator for Trocar Insertion
Trocar insertion is a critical first step of all minimally invasive surgery; however, it also carries a high risk for errors. Studies suggest that entry errors are the most common complication in laparoscopic surgery with 4% of errors leading to patient fatality. Surgeon error due to excessive force is often the cause for entry errors; however, adequate training has been shown to reduce the risk of these surgical errors. In practice, institutions lack widespread and relatively inexpensive means to train surgeons for trocar entry that does not involve patient risk. In our prior work, we presented a simple Stewart platform haptic device with a numerical model to simulate key force characteristics of trocar insertion. Evaluation in our first study was limited to device characterization. In this paper, we present a more robust haptic mechanism with higher fidelity linear actuators, an increased workspace, and tissue visualization to accompany haptic cues. We also present a novel upper module that allows for a sudden drop of the trocar after the final puncture event to create a more realistic simulation. We performed a user study with eight novices to investigate how well the device and visualization train users in the trocar insertion procedure. By the end of the experiment, subjects using the device had a normalized error reduction of roughly 85% on average, relative to themselves. This device shows potential for widespread training of trocar insertion, possibly leading to fewer complications and deaths following the procedure. Finally, our upper module also represents an innovative addition for traditional admittance-type haptic device designs, not typically capable of accurately representing motion in free space.
- 24 September 2024
- Published by World Scientific Pub Co Pte Ltd in Journal of Medical Robotics Research
- Vol. 09 (03n04)
Training with a Visual-Haptic Simulator for Trocar Insertion
Trocar insertion is a critical first step of all minimally invasive surgery; however, it also carries a high risk for errors. Studies suggest that entry errors are the most common complication in laparoscopic surgery with 4% of errors leading to patient fatality. Surgeon error due to excessive force is often the cause for entry errors; however, adequate training has been shown to reduce the risk of these surgical errors. In practice, institutions lack widespread and relatively inexpensive means to train surgeons for trocar entry that does not involve patient risk. In our prior work, we presented a simple Stewart platform haptic device with a numerical model to simulate key force characteristics of trocar insertion. Evaluation in our first study was limited to device characterization. In this paper, we present a more robust haptic mechanism with higher fidelity linear actuators, an increased workspace, and tissue visualization to accompany haptic cues. We also present a novel upper module that allows for a sudden drop of the trocar after the final puncture event to create a more realistic simulation. We performed a user study with eight novices to investigate how well the device and visualization train users in the trocar insertion procedure. By the end of the experiment, subjects using the device had a normalized error reduction of roughly 85% on average, relative to themselves. This device shows potential for widespread training of trocar insertion, possibly leading to fewer complications and deaths following the procedure. Finally, our upper module also represents an innovative addition for traditional admittance-type haptic device designs, not typically capable of accurately representing motion in free space.
- Open Access
- 1 April 2024
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 42 (10) , 1102-1109
Normal Risk Ovarian Screening Study: 21-Year Update
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. PURPOSE: The Normal Risk Ovarian Screening Study (NROSS) tested a two-stage screening strategy in postmenopausal women at conventional hereditary risk where significantly rising cancer antigen (CA)-125 prompted transvaginal sonography (TVS) and abnormal TVS prompted surgery to detect ovarian cancer. METHODS: A total of 7,856 healthy postmenopausal women were screened annually for a total of 50,596 woman-years in a single-arm study (ClinicalTrials.gov identifier: NCT00539162 ). Serum CA125 was analyzed with the Risk of Ovarian Cancer Algorithm (ROCA) each year. If risk was unchanged and <1:2,000, women returned in a year. If risk increased above 1:500, TVS was undertaken immediately, and if risk was intermediate, CA125 was repeated in 3 months with a further increase in risk above 1:500 prompting referral for TVS. An average of 2% of participants were referred to TVS annually. RESULTS: Thirty-four patients were referred for operations detecting 15 ovarian cancers and two borderline tumors with 12 in early stage (I-II). In addition, seven endometrial cancers were detected with six in stage I. As four ovarian cancers and two borderline tumors were diagnosed with a normal ROCA, the sensitivity for detecting ovarian and borderline cancer was 74% (17 of 23), and 70% of ROCA-detected cases (12 of 17) were in stage I-II. NROSS screening reduced late-stage (III-IV) disease by 34% compared with UKCTOCS controls and by 30% compared with US SEER values. The positive predictive value (PPV) was 50% (17 of 34) for detecting ovarian cancer and 74% (25 of 34) for any cancer, far exceeding the minimum acceptable study end point of 10% PPV. CONCLUSION: While the NROSS trial was not powered to detect reduced mortality, the high specificity, PPV, and marked stage shift support further development of this strategy.
- 1 April 2024
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 42 (10) , 1102-1109
Open AccessNormal Risk Ovarian Screening Study: 21-Year Update
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. PURPOSE: The Normal Risk Ovarian Screening Study (NROSS) tested a two-stage screening strategy in postmenopausal women at conventional hereditary risk where significantly rising cancer antigen (CA)-125 prompted transvaginal sonography (TVS) and abnormal TVS prompted surgery to detect ovarian cancer. METHODS: A total of 7,856 healthy postmenopausal women were screened annually for a total of 50,596 woman-years in a single-arm study (ClinicalTrials.gov identifier: NCT00539162 ). Serum CA125 was analyzed with the Risk of Ovarian Cancer Algorithm (ROCA) each year. If risk was unchanged and <1:2,000, women returned in a year. If risk increased above 1:500, TVS was undertaken immediately, and if risk was intermediate, CA125 was repeated in 3 months with a further increase in risk above 1:500 prompting referral for TVS. An average of 2% of participants were referred to TVS annually. RESULTS: Thirty-four patients were referred for operations detecting 15 ovarian cancers and two borderline tumors with 12 in early stage (I-II). In addition, seven endometrial cancers were detected with six in stage I. As four ovarian cancers and two borderline tumors were diagnosed with a normal ROCA, the sensitivity for detecting ovarian and borderline cancer was 74% (17 of 23), and 70% of ROCA-detected cases (12 of 17) were in stage I-II. NROSS screening reduced late-stage (III-IV) disease by 34% compared with UKCTOCS controls and by 30% compared with US SEER values. The positive predictive value (PPV) was 50% (17 of 34) for detecting ovarian cancer and 74% (25 of 34) for any cancer, far exceeding the minimum acceptable study end point of 10% PPV. CONCLUSION: While the NROSS trial was not powered to detect reduced mortality, the high specificity, PPV, and marked stage shift support further development of this strategy.
- 29 March 2024
- Published by Elsevier in Gynecologic Oncology
- Vol. 183, 85-92
System-level recommendations for improved wellness for gynecologic oncologists: A Society of Gynecologic Oncology Review
- 29 March 2024
- Published by Elsevier in Gynecologic Oncology
- Vol. 183, 85-92
System-level recommendations for improved wellness for gynecologic oncologists: A Society of Gynecologic Oncology Review
- 24 March 2024
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 31 (6) , 518-524
Demographics and Characteristics of US-Based Minimally Invasive Gynecologic Surgery Fellowship Program Directors: A 2023 Descriptive Analysis
- 24 March 2024
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 31 (6) , 518-524
Demographics and Characteristics of US-Based Minimally Invasive Gynecologic Surgery Fellowship Program Directors: A 2023 Descriptive Analysis
- 3 November 2023
- Published by Elsevier in Gynecologic Oncology
- Vol. 179, 63-69
Survival differences by race and surgical approach in early-stage operable cervical Cancer
- 3 November 2023
- Published by Elsevier in Gynecologic Oncology
- Vol. 179, 63-69
Survival differences by race and surgical approach in early-stage operable cervical Cancer
- Open Access
- 8 February 2022
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 8 (1) , e31263
Understanding the Information Needs of Patients With Ovarian Cancer Regarding Genetic Testing to Inform Intervention Design: Interview Study
Background: Experts in gynecological cancer care recommend that all patients with invasive or high-grade ovarian cancer (OC) undergo genetic testing. However, even patients who intend to take or have taken genetic tests have many unaddressed information needs regarding genetic testing. Existing genetic counseling falls short of adequately addressing this challenge. Objective: This study aims to investigate the genetic testing–related information needs of patients with OC to inform the design of interactive technology-based interventions that can enhance communication of genetic testing information to patients. Methods: We interviewed 20 patients with OC who had taken genetic tests and gathered genetic testing–related messages from an active OC web-based community. The interview transcripts and web-based community messages were analyzed using the qualitative content analysis method. Results: Data analyses produced a comprehensive taxonomy of the genetic testing–related information needs of patients with OC, which included five major topic clusters: knowledge of genetic testing as a medical test, genetic testing process, genetic testing implications for patients, implications for family members, and medical terminology. Findings indicated that patients wanted to receive information that was relevant, understandable, concise, usable, appropriate, sympathetic, and available when needed. They also preferred various channels to receive information, including internet-based technologies, print, and conversations with health care providers. Conclusions: Patients with OC need a range of information to address the uncertainties and challenges that they encounter while taking genetic tests. Their preferences for channels to receive information vary widely. A multichannel information delivery solution that combines both provider-led and peer-to-peer education models is needed to supplement existing genetic counseling to effectively meet the genetic testing–related information needs of patients with OC.
- 8 February 2022
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 8 (1) , e31263
Open AccessUnderstanding the Information Needs of Patients With Ovarian Cancer Regarding Genetic Testing to Inform Intervention Design: Interview Study
Background: Experts in gynecological cancer care recommend that all patients with invasive or high-grade ovarian cancer (OC) undergo genetic testing. However, even patients who intend to take or have taken genetic tests have many unaddressed information needs regarding genetic testing. Existing genetic counseling falls short of adequately addressing this challenge. Objective: This study aims to investigate the genetic testing–related information needs of patients with OC to inform the design of interactive technology-based interventions that can enhance communication of genetic testing information to patients. Methods: We interviewed 20 patients with OC who had taken genetic tests and gathered genetic testing–related messages from an active OC web-based community. The interview transcripts and web-based community messages were analyzed using the qualitative content analysis method. Results: Data analyses produced a comprehensive taxonomy of the genetic testing–related information needs of patients with OC, which included five major topic clusters: knowledge of genetic testing as a medical test, genetic testing process, genetic testing implications for patients, implications for family members, and medical terminology. Findings indicated that patients wanted to receive information that was relevant, understandable, concise, usable, appropriate, sympathetic, and available when needed. They also preferred various channels to receive information, including internet-based technologies, print, and conversations with health care providers. Conclusions: Patients with OC need a range of information to address the uncertainties and challenges that they encounter while taking genetic tests. Their preferences for channels to receive information vary widely. A multichannel information delivery solution that combines both provider-led and peer-to-peer education models is needed to supplement existing genetic counseling to effectively meet the genetic testing–related information needs of patients with OC.
- Open Access
- 15 June 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Understanding the Information Needs of Patients With Ovarian Cancer Regarding Genetic Testing to Inform Intervention Design: Interview Study (Preprint)
BACKGROUND Experts in gynecological cancer care recommend that all patients with invasive or high-grade ovarian cancer (OC) undergo genetic testing. However, even patients who intend to take or have taken genetic tests have many unaddressed information needs regarding genetic testing. Existing genetic counseling falls short of adequately addressing this challenge. OBJECTIVE This study aims to investigate the genetic testing–related information needs of patients with OC to inform the design of interactive technology-based interventions that can enhance communication of genetic testing information to patients. METHODS We interviewed 20 patients with OC who had taken genetic tests and gathered genetic testing–related messages from an active OC web-based community. The interview transcripts and web-based community messages were analyzed using the qualitative content analysis method. RESULTS Data analyses produced a comprehensive taxonomy of the genetic testing–related information needs of patients with OC, which included five major topic clusters: knowledge of genetic testing as a medical test, genetic testing process, genetic testing implications for patients, implications for family members, and medical terminology. Findings indicated that patients wanted to receive information that was relevant, understandable, concise, usable, appropriate, sympathetic, and available when needed. They also preferred various channels to receive information, including internet-based technologies, print, and conversations with health care providers. CONCLUSIONS Patients with OC need a range of information to address the uncertainties and challenges that they encounter while taking genetic tests. Their preferences for channels to receive information vary widely. A multichannel information delivery solution that combines both provider-led and peer-to-peer education models is needed to supplement existing genetic counseling to effectively meet the genetic testing–related information needs of patients with OC.
- 15 June 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessUnderstanding the Information Needs of Patients With Ovarian Cancer Regarding Genetic Testing to Inform Intervention Design: Interview Study (Preprint)
BACKGROUND Experts in gynecological cancer care recommend that all patients with invasive or high-grade ovarian cancer (OC) undergo genetic testing. However, even patients who intend to take or have taken genetic tests have many unaddressed information needs regarding genetic testing. Existing genetic counseling falls short of adequately addressing this challenge. OBJECTIVE This study aims to investigate the genetic testing–related information needs of patients with OC to inform the design of interactive technology-based interventions that can enhance communication of genetic testing information to patients. METHODS We interviewed 20 patients with OC who had taken genetic tests and gathered genetic testing–related messages from an active OC web-based community. The interview transcripts and web-based community messages were analyzed using the qualitative content analysis method. RESULTS Data analyses produced a comprehensive taxonomy of the genetic testing–related information needs of patients with OC, which included five major topic clusters: knowledge of genetic testing as a medical test, genetic testing process, genetic testing implications for patients, implications for family members, and medical terminology. Findings indicated that patients wanted to receive information that was relevant, understandable, concise, usable, appropriate, sympathetic, and available when needed. They also preferred various channels to receive information, including internet-based technologies, print, and conversations with health care providers. CONCLUSIONS Patients with OC need a range of information to address the uncertainties and challenges that they encounter while taking genetic tests. Their preferences for channels to receive information vary widely. A multichannel information delivery solution that combines both provider-led and peer-to-peer education models is needed to supplement existing genetic counseling to effectively meet the genetic testing–related information needs of patients with OC.
- 1 April 2019
- Published by Wiley in Psycho-Oncology
- Vol. 28 (5) , 1153-1156
Evaluating medically underserved gynecologic oncology patient survivors' interest in participating as a volunteer mentor in a peer support group
- 1 April 2019
- Published by Wiley in Psycho-Oncology
- Vol. 28 (5) , 1153-1156
Evaluating medically underserved gynecologic oncology patient survivors' interest in participating as a volunteer mentor in a peer support group
- 1 March 2017
- Published by Elsevier in Gynecologic Oncology
- Vol. 144 (3) , 547-552
Prognostic value of endocervical sampling following loop excision of high grade intraepithelial neoplasia
- 1 March 2017
- Published by Elsevier in Gynecologic Oncology
- Vol. 144 (3) , 547-552
Prognostic value of endocervical sampling following loop excision of high grade intraepithelial neoplasia